|
RequipDrug - Requip The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Ropinirole Hydrochloride
Strength -
EQ 0.25MG BASE
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020658
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 19, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Requip
Vioxx 12.5mg Tablet; Oral
Vioxx 25mg Tablet; Oral Vioxx 50mg Tablet; Oral Requip Eq 0.25mg Base Tablet; Oral Maxalt Eq 5mg Base Tablet; Oral Zemuron 10mg/ml Injectable; Injection Zemuron (p/f) 100mg/10ml(10mg/ml) Injectable; Injection Zemuron (p/f) 50mg/5ml(10mg/ml) Injectable; Injection Vioxx 12.5mg/5ml Suspension; Oral Vioxx 25mg/5ml Suspension; Oral NewDrugInformation |